Global Health Campus,
Chemin du Pommier 40,
1218 Le Grand-Saconnex, Geneva, Switzerland
ITB-Iplus/GDF-MED/2025/1_ITB document pretomanid 200mg
TPMAT Recommendations - Round 30 (EOI Released February 2025)
2025-01_QA Notice_USFDA Warning letter_Mylan Indore Pithampur site
ITB document ITB-Iplus/GDF-MED/2024/3
Annex L. TB medicines target prices ITB-Iplus/GDF-MED/2024/3
Annex K. Form for Requests for Clarifications or Complaints ITB-Iplus/GDF-MED/2024/3
Annex J. Global Drug Facility artwork development guidelines ITB-Iplus/GDF-MED/2024/3
Annex I. GMSD address list ITB-Iplus/GDF-MED/2024/3
Annex H. Indicative non-binding estimated quantities ITB-Iplus/GDF-MED/2024/3
Annex G. GDF access to supplier information for WHO PQP and ERP assessed TB medicines ITB-Iplus/GDF-MED/2024/3
Pagination
- Previous page
- Page 3
- Next page